Insomnia due to nervous and mental fatigue; neurocirculatory dystonia with tachycardia, cardialgia and arterial hypertension; decreased appetite.
Composition and form of release
The drug Trivalumene is produced in the form of hard gelatin capsules with a green lid and a yellow body, inside of which there is a powder from yellowish-brown to brownish-brown color, which has a weak specific odor. There may also be white blotches and visible particles. Main elements: sedative collection (common hop cones, motherwort herb, peppermint leaves, roots and rhizomes of licorice, rhizomes with valerian roots), as additional substances in the composition are indicated: lactose, calcium stearate, titanium dioxide, erythrosine, quinoline yellow, indigotin , gelatin.
Trivalumen belongs to the group of psycholeptic drugs. Sedative and hypnotic herbal preparation, which has a complex sedative effect on the central nervous system, reduces psycho-emotional stress, has a sedative effect, eliminates sleep disturbances, and reduces excessive sensitivity to external stimuli. The drug can be taken for a long time, it does not cause drug dependence.
The drug Travalumene is prescribed and used to patients for the treatment of mild forms of neurosis and neurasthenia, which are accompanied by anxiety, increased excitability, tension and a sense of fear, depression, irritability and fatigue. This drug is indicated for arterial hypertension, cardiovascular neuroses with cardialgia. For mild sleep disorders due to mental or nervous fatigue, disorders of concentration and memory, constant psycho-emotional stress, climacteric syndrome, Trivalumene is also used.
The drug Trivalumene is contraindicated for use if the patient has acute inflammatory diseases of the intestine and stomach, stomach ulcers, irritable bowel syndrome, hypokalemia, impaired functional activity of the kidneys and liver, bronchial asthma, severe obesity. Also, the drug is contraindicated in patients with intolerance to the components that make up this drug, depression and other diseases that are accompanied by inhibition of the activity of the central nervous system.
Application during pregnancy and lactation
The use of the drug Trivalumene during pregnancy and breastfeeding is contraindicated.
Method of administration and dosage
The drug Trivalumene is intended for oral administration; adults and children over 12 years old should take 1 capsule in the morning and evening (1-2 times a day) 15-20 minutes before meals. The permissible daily dose is 2 capsules.
In case of sleep disorders, the drug should be taken 1 time, 1-2 capsules, in the evening before going to bed.
The duration of therapy is about a week, if necessary, after 1-2 weeks, the treatment can be repeated.
In case of an overdose with Trivalumen, the following symptoms may appear:
- hearing and visual acuity disorders;
- general weakness;
- mental agitation;
- imbalance in water and electrolyte balance;
- severe fatigue;
- increased manifestations of adverse reactions.
As a treatment, if any symptoms appear, you need to rinse the stomach and conduct symptomatic therapy.
The use of the drug Trivalumen is usually well tolerated by patients, but nevertheless, sometimes this remedy can cause the manifestation of side effects, such as: drowsiness, fatigue, weakness, headache, decreased performance, dizziness, depression, depression of emotional reactions, lowering blood pressure. spastic abdominal pain, nausea, hypokalemia. Also, in some patients, manifestations of dyspepsia, hypersensitivity reactions (hyperemia, itching, rash, urticaria, skin edema) are possible.
Storage conditions and periods
The main conditions for storing the drug Trivalumen are inaccessibility to children, original packaging and temperature not higher than + 25 ° C. The shelf life is 2 years.